
Teva Pharmaceutical Industries ADR Representing One
Price
Price
CHART BY
Frequently asked questions
What is Teva Pharmaceutical Industries ADR Representing One's market capitalization?
What is the Earnings Per Share (EPS) for Teva Pharmaceutical Industries ADR Representing One?
What are the analyst ratings and target price for Teva Pharmaceutical Industries ADR Representing One's stock?
What is Teva Pharmaceutical Industries ADR Representing One's revenue over the trailing twelve months?
What is the EBITDA for Teva Pharmaceutical Industries ADR Representing One?
What is the free cash flow of Teva Pharmaceutical Industries ADR Representing One?
How many employees does Teva Pharmaceutical Industries ADR Representing One have, and what sector and industry does it belong to?
What is the free float of Teva Pharmaceutical Industries ADR Representing One's shares?
Financials
- Market Cap
- $15.81B
- EPS (TTM)
- -$1.448
- Free Float
- 1.15B
- Revenue (TTM)
- $16.53B
- EBITDA (TTM)
- $4.41B
- Free Cashflow (TTM)
- $2.04B
Pricing
- 1D span
- $13.40$14.91
- 52W span
- $12.51$22.80
Analyst Ratings
The price target is $23.67 and the stock is covered by 11 analysts.
Buy
8
Hold
3
Sell
0
Information
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
- Employees
- 36,167
- Industries
- Generic Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US8816242098
- Primary Ticker
- TEVA